Book contents
- Frontmatter
- Contents
- PREFACE
- 1 1894: “The foremost medical question of the day”
- 2 The Mulford Story
- 3 A Sharp & Dohme Interlude
- 4 The Virology Network and a New Program at Merck Sharp & Dohme
- 5 Hilleman's Innovations: First Phase
- 6 Dangerous Interlude
- 7 Transforming Bacteriology: A Second Phase
- 8 New Networks, New Leadership: The Hepatitis B Vaccines
- 9 Vaccine Innovation in the Nineties: New Strategies, New Opportunities, and Public Confrontations
- 10 Historical Perspectives on the Process of Innovation
- ACKNOWLEDGMENTS
- A WORD ABOUT SOURCES
- INDEX
- Plate section
Plate section
Published online by Cambridge University Press: 06 July 2010
- Frontmatter
- Contents
- PREFACE
- 1 1894: “The foremost medical question of the day”
- 2 The Mulford Story
- 3 A Sharp & Dohme Interlude
- 4 The Virology Network and a New Program at Merck Sharp & Dohme
- 5 Hilleman's Innovations: First Phase
- 6 Dangerous Interlude
- 7 Transforming Bacteriology: A Second Phase
- 8 New Networks, New Leadership: The Hepatitis B Vaccines
- 9 Vaccine Innovation in the Nineties: New Strategies, New Opportunities, and Public Confrontations
- 10 Historical Perspectives on the Process of Innovation
- ACKNOWLEDGMENTS
- A WORD ABOUT SOURCES
- INDEX
- Plate section
Summary
- Type
- Chapter
- Information
- Networks of InnovationVaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995Publisher: Cambridge University PressPrint publication year: 1996